IN THE MIDDLE OF MARCH, PFIZER CHIEF Albert Bourla beamed into a Webex video call with the leaders of the American pharmaceutical giant’s vaccine research and manufacturing groups.
The two teams had worked late into the night on a robust development plan for Pfizer’s experimental Covid-19 vaccine and told Bourla that they aimed to make it available lightning-fast. It could be ready sometime in 2021.
“Not good enough,” Bourla said. The faces of the researchers tensed up, and conscious of the Herculean effort that had taken place, Bourla made sure to thank them. But he also kept pushing. He asked if people on the call thought the virus might come back in the fall, and what they expected would happen if a vaccine were not available when a new flu season hit at the same time, an issue the federal Centers for Disease Control raised weeks later.
“Think in different terms,” Bourla told them. “Think you have an open checkbook, you don’t need to worry about such things. Think that we will do things in parallel, not sequential. Think you need to build manufacturing of a vaccine before you know what’s working. If it doesn’t, let me worry about it and we will write it off and throw it out.”
Says Mikael Dolsten, Pfizer’s chief scientific officer: “He challenged the team to aim for a moon shot-like goal — to have millions of doses of vaccine in the hands of vulnerable populations before the end of the year.”
This story is from the August - September 2020 edition of Forbes Africa.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the August - September 2020 edition of Forbes Africa.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber? Sign In
Down To Earth
A new era in satellite technology offers space-down insight. Here are some fascinating world views.
Could A Digital Twin Save Your Life?
Human digital twins are quickly moving beyond manufacturing and into the medical world advancing cancer care, soeeding up drug development, personalizing clinical trials, and much more.
The All-Rounder In Ecotourism
An exclusive interview with renowned Kenya-born landscape architect and pioneer of sustainable tourism Hitesh Mehta. His other fascinating career? Representing East Africa and Kenya in first-class cricket and playing in three ICC World Cup tournaments in the late 1970s and 1980s.
Wheeler-Deeler
Alex Bouaziz’s HR company became the fastest-growing software startup in Silicon Valley history by promising to take the pain out of overseas hiring. But in its rush to a $12 billion valuation, regulators worry it may have been cutting the very compliance corners it’s supposedly maintaining.
Culture Couture
Niger designer Alia Baré, also the daughter of a former president, is working to weave together a positive narrative of her country through fashion.
'We Can Build A Real Unicorn Out Of Africa, Creating Impact'
Manish Sardana, the Nairobi-based co-founder of edtech startup Craydel, wants to democratize access to higher education in Africa and eradicate the study-abroad agent market.
A Record Year For Elections, 2024 Will Determine Global Geopolitics
We are all hopeful that 2024 will definitely bring better sense to people, particularly to those in power to make sincere amends to the lapses of the past.
For The Record
A Brazilian producer and a Kenyan singer came together to create a song last year that sOared ujp music charts globally, and in collaborating With a an India-born director for the video, it is NOW a milestone for African sound.
The Best Game
SA20 Commissioner and former South African cricketer Graeme Smith on the ambition to create the biggest league outside of India, and why putting on a show off the pitch is as important to attract a new audience.
Cream Of The Crop
Food is the future and these proactive startups are focused on shifting agricultural practices to prepare for what is to come.